Sean Parker’s cancer institute may have found a blood test to see if patients will respond to treatment

SOURCE:techcrunch.com




Scientists in collaboration with tech billionaire Sean Parker’s Institute for Cancer Immunotherapy may have found a way to predict whether melanoma patients will respond to treatments that target the PD-1 (programmed cell death protein) pathway in tumors through a. view full post